Tirbanibulin for Pediatric Warts

Inclusion Criteria:

1. Age 8-18

2. Subject and their legally authorized representative must be able to understand andbe willing to adhere to all protocol requirements and voluntarily sign and dateinformed consent and assent for minors.

3. Subject is judged to be in good health as determined by the Principal Investigator,based upon the results of the screening assessments and medical history.

4. Diagnosis of warts on the hands

5. Wart count on the hands and 3-10

Exclusion Criteria:

1. Wart duration >2 years.

2. More than 10 warts in non-hand areas.

3. Total wart surface area on the hands bigger than 100 cm2

4. Prior treatment failure with the following modalities:

5. intralesional immunotherapy 2. intralesional bleomycin, 5-fluorouracil, methotrexate

6. intralesional cidofovir 5. Any over the counter, prescription topical, orin-office procedural wart treatment within 6 weeks of baseline (Day 1) 6. Knownimmuno-suppressed state due to disease or medication, medical treatment o 7. Knownallergy to any component of the IP 8. Any conditions that, in the PrincipalInvestigator's opinion, may interfere with the course of the study